 |
市场调查报告书
商品编码
1441342
全球癌症生物标记市场规模、份额、成长分析（按分析技术、生物分子、癌症、应用）- 2023-2030 年产业预测Global Cancer Biomarkers Market Size, Share, Growth Analysis, By Profiling Technology, By Biomolecules, By Cancer, By Application - Industry Forecast 2023-2030 |
||||||
2022年全球癌症生物标记市场规模为132.4亿美元，预计将从2023年的148.3亿美元成长到2031年的294.9亿美元，预测期内（2024-2031年）复合CAGR为13.6%
全球癌症生物标记市场的预期扩张显示多种癌症的发生率显着增加，包括肺癌、前列腺癌和乳腺癌。癌症病例的增加将推动预测期内市场的成长。
此外，标靶和生物疗法在癌症治疗中日益重要，也推动了对有效生物标记的需求。这种上升趋势得到了技术进步的进一步支持，这些技术进步提高了癌症生物标记的精确度和一致性，从而提高了治疗监测和诊断能力。
全球癌症生物标记市场細項分析
全球癌症生物标记市场由五个部分组成：分析技术、癌症类型、生物分子、应用和地理。根据分析技术，市场分为四个部分：基于细胞遗传学的测试、免疫分析、影像技术和组学技术。市场根据生物分子分为四个部分：遗传、蛋白质、糖和表观遗传生物标记。市场依癌症种类分为：乳癌、肺癌、大肠癌、摄护腺癌、胃癌等。该市场根据应用分为五个部分：风险评估、预测、药物发现和开发、诊断等。市场分为以下区域：亚太地区、日本、中国、印度、韩国、澳洲、亚太地区其他地区、拉丁美洲、巴西、沙乌地阿拉伯、欧洲其他地区、北美、美国、加拿大、墨西哥、欧洲、德国、英国、义大利、法国、西班牙和拉丁美洲地区其他地区。
全球生物样本库市场的驱动因素
许多製药公司正在大力投资尖端研究和开发项目，这些项目以专为癌症检测和治疗而设计的新生物标记为中心。许多令人感兴趣的潜在客户的发展阶段已接近尾声，在首次亮相时应该会取得显着进步。这些可能的生物标记有能力透过提高精确度和有效性来彻底改变癌症的诊断和治疗方式。
全球癌症生物标记市场的限制
癌症生物标记产业的一个主要障碍与全球癌症盛行率不断上升以及对诊断工具不断增长的需求形成鲜明对比。成熟国家和新兴国家都缺乏全面的生物标记测试报销规则。这项缺陷阻碍了这些基本诊断工具的广泛采用，从而限制了全球对生物标记的需求。另一个重大障碍是癌症检测和治疗的高昂费用，这在发展中国家尤其常见。
全球癌症生物标记市场趋势
由于许多重要因素的结合，癌症生物标记市场预计在未来十年将显着增长。患者和医疗保健专业人士对恶性肿瘤治疗早期检测需求的认识不断增强是这一增长的关键因素。这种意识的提高鼓励以积极主动的方式进行早期诊断，从而及时进行治疗，从而可能带来更好的治疗结果。
目录
执行摘要
- 市场概况
- 命运之轮
研究方法论
- 资讯采购
- 二手和主要资料来源
- 市场规模估计
- 市场假设与限制
母公司市场分析
- 市场概况
- 市场规模
- 市场动态
- 司机
- 机会
- 限制
- 挑战
主要市场洞察
- 技术分析
- 定价分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- 启动分析
- 原料分析
- 创新矩阵
- 管道产品分析
- 总体经济指标
- 顶级投资分析
- 成功的关键因素
- 竞争程度
市场动态与展望
- 市场动态
- 司机
- 机会
- 限制
- 挑战
- 监管环境
- 波特分析
- 对未来颠覆的特别见解
按分析技术分類的全球癌症生物标记市场
- 市场概况
- 欧米克科技
- 影像技术
- 免疫测定
- 基于细胞遗传学的测试
按生物分子分類的全球癌症生物标记市场
- 市场概况
- 基因生物标记
- 蛋白质生物标记
- 表观遗传学
- 和糖生物标记
按癌症分類的全球癌症生物标记市场
- 市场概况
- 乳癌
- 肺癌
- 大肠直肠癌
- 摄护腺癌
- 胃癌
- 和别的
全球癌症生物标记市场（按应用）
- 市场概况
- 诊断
- 药物发现与开发
- 预测
- 风险评估
- 和别的
按地区分類的全球癌症生物标记市场规模
- 市场概况
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 拉丁美洲其他地区
- 中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分
竞争格局
- 前 5 名玩家比较
- 2021 年关键参与者的市场定位
- 主要市场参与者所采取的策略
- 最佳制胜策略
- 近期市集活动
- 主要公司市占率（%），2021年
主要公司简介
- F. Hoffmann-LA Roche Ltd.
- Siemens AG
- Thermo Fisher Scientific, Inc.
- Merck & Co, Inc.
- Agilent Technologies Inc.
- Bristol-Myers Squibb Company
- Qiagen NV
- Exact Sciences Corporation
- Novartis AG
- Bio-Rad Laboratories
- Hologic, Inc.
- bioMerieux SA
- Abbott Laboratories
- PerkinElmer, Inc.
- Illumina
Global Cancer Biomarkers Market size was valued at USD 13.24 Billion in 2022 and is poised to grow from USD 14.83 Billion in 2023 to USD 29.49 Billion by 2031, growing at a CAGR of 13.6% in the forecast period (2024-2031)
The anticipated expansion of the worldwide market for cancer biomarkers is indicative of a significant increase in the incidence of many cancer kinds, including lung, prostate, and breast cancer. The increase in cancer cases is what will fuel the market's growth during the projection period.
Furthermore, the need for efficient biomarkers is fueled by the growing importance of targeted and biological therapies in the treatment of cancer. This rising trajectory is further supported by technological improvements that improve the precision and consistency of cancer biomarkers, which in turn improves treatment monitoring and diagnostic capacities.
Global Cancer Biomarkers Market Segmental Analysis
Five segments comprise the global market for cancer biomarkers: profiling technique, cancer type, biomolecule, application, and geography. The market is divided into four segments based on profiling technology: cytogenetics-based tests, immunoassays, imaging technologies, and omic technologies. The market is divided into four segments based on biomolecules: genetic, protein, glyco-, and epigenetic biomarkers. The market is divided into categories according to the kind of cancer: breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, and others. The market is divided into five segments based on application: risk assessment, prognostics, drug discovery and development, diagnostics, and others. The market is divided into the following regions: Asia-Pacific, Japan, China, India, South Korea, Australia, Rest of Asia-Pacific, LAMEA, Brazil, Saudi Arabia, Rest of Europe, North America, U.S., Canada, Mexico, Europe, Germany, UK, Italy, France, Spain, and Rest of LAMEA.
Drivers of the Global Biobanking Market
Many pharmaceutical companies are investing heavily in cutting-edge research and development projects centered on new biomarkers designed for cancer detection and therapy. A number of intriguing prospects are almost finished with their development stages and should advance significantly when they debut. These possible biomarkers have the capacity to completely transform the way that cancer is diagnosed and treated by providing increased precision and effectiveness.
Restraints in the Global Cancer Biomarkers Market
A major barrier in the cancer biomarker industry contrasts with the rising global prevalence of cancer and the growing need for diagnostic tools. the lack of comprehensive biomarker test reimbursement rules in both established and emerging countries. This deficiency limits the global demand for biomarkers by impeding the widespread adoption of these essential diagnostic tools. Another significant obstacle is the high expense of cancer detection and treatment, which is particularly common in developing nations.
Market Trends of the Global Cancer Biomarkers Market
The market for cancer biomarkers is expected to grow significantly over the next ten years due to a number of important elements coming together. Growing patient and healthcare professional knowledge of the need of early detection in treating malignancies is a key factor in this growth. This increased consciousness encourages early diagnosis in a proactive manner, resulting in prompt treatments that may lead to better treatment outcomes.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Cancer Biomarkers Market by Profiling Technology
- Market Overview
- Omic Technologies
- Imaging Technologies
- Immunoassays
- and Cytogenetics-based Tests
Global Cancer Biomarkers Market by Biomolecules
- Market Overview
- Genetic Biomarkers
- Protein Biomarkers
- Epigenetics
- and Glyco-biomarkers
Global Cancer Biomarkers Market by Cancer
- Market Overview
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- and Others
Global Cancer Biomarkers Market by Application
- Market Overview
- Diagnostics
- Drug Discovery and Development
- Prognostics
- Risk Assessment
- and Others
Global Cancer Biomarkers Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- F. Hoffmann-LA Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol-Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Exact Sciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
儿科癌症生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按适应症、类型、最终用途、地区和竞争细分，2019-2029F
癌症生物标记市场，按生物标记类型、癌症类型、应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
癌症生物标记市场规模、份额、成长分析，按分析技术、按癌症类型、按产品、按应用、按地区 - 行业预测，2024-2031 年
儿科癌症生物标记市场规模、份额、趋势分析报告：按适应症、按生物标记、按最终用途、细分市场预测，2024-2030 年
2024-2032 年按分析技术、生物分子、癌症类型、应用、最终用户和地区分類的癌症生物标记市场报告
癌症生物标记市场规模、份额、趋势分析报告：按类型、生物分子、应用、技术、地区和细分市场预测，2024-2030
癌症生物标记市场：按生物标记类型、癌症类型、技术、应用、最终用户 - 2024-2030 年全球预测
全球癌症生物标记市场：按分析技术、按癌症类型、按产品、按应用、按最终用户、按地区 - 预测至 2029 年
癌症生物标记市场 - 按生物标记类型、癌症类型和关键地区：行业趋势和全球预测
癌症生物标记市场，按生物标记类型，按癌症类型，按分析技术，按最终用户，按地理位置